Final progression-free survival results from the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancer

JOURNAL ARTICLE published January 2020 in Lung Cancer

Authors: Kazuhiko Nakagawa | Toyoaki Hida | Hiroshi Nokihara | Masahiro Morise | Koichi Azuma | Young Hak Kim | Takashi Seto | Yuichi Takiguchi | Makoto Nishio | Hiroshige Yoshioka | Toru Kumagai | Katsuyuki Hotta | Satoshi Watanabe | Koichi Goto | Miyako Satouchi | Toshiyuki Kozuki | Ryo Koyama | Tetsuya Mitsudomi | Nobuyuki Yamamoto | Takashi Asakawa | Morihiko Hayashi | Wakako Hasegawa | Tomohide Tamura